JOEL BYRON NELSON
Medical Practice in Pittsburgh, PA

License number
Pennsylvania MD069351L
Category
Medicine
Type
Medical Physician and Surgeon
Address
Address
Pittsburgh, PA 15232

Professional information

See more information about JOEL BYRON NELSON at trustoria.com
Joel B Nelson Photo 1
Dr. Joel B Nelson, Pittsburgh PA - MD (Doctor of Medicine)

Dr. Joel B Nelson, Pittsburgh PA - MD (Doctor of Medicine)

Specialties:
Urology
Address:
Univ Of Pittsburgh Phys Urology
5200 Centre Ave SUITE 209, Pittsburgh 15232
(412) 692-4100 (Phone)
Certifications:
Urology, 2008
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Northwestern Center Feinberg School of Medicine
Graduated: 1988


Joel Nelson Photo 2
Joel Nelson, Pittsburgh PA

Joel Nelson, Pittsburgh PA

Work:
Department of Urology
5200 Centre Ave, Pittsburgh, PA 15232


Joel B Nelson Photo 3
Joel B Nelson, Pittsburgh PA

Joel B Nelson, Pittsburgh PA

Specialties:
Urologist
Address:
5200 Centre Ave, Pittsburgh, PA 15232
3471 5Th Ave, Pittsburgh, PA 15213
Board certifications:
American Board of Urology Certification in Urology


Joel Nelson Photo 4
Methods For Diagnosing Prostate Cancer And Predicting Prostate Cancer Relapse

Methods For Diagnosing Prostate Cancer And Predicting Prostate Cancer Relapse

US Patent:
2013007, Mar 28, 2013
Filed:
Sep 14, 2012
Appl. No.:
13/619556
Inventors:
Jianhua Luo - Wexford PA, US
George Konstantine Michalopoulos - Pittsburg PA, US
Joel Byron Nelson - Pittsburgh PA, US
Chi Song - New Haven CT, US
Chien-Cheng Tseng - Pittsburgh PA, US
Yanping Yu - Wexford PA, US
International Classification:
C12Q 1/68
US Classification:
506 9
Abstract:
The present invention relates to methods and compositions for diagnosing prostate cancer and/or determining whether a prostate cancer patient is at increased risk of suffering a relapse, or a rapid relapse, of his cancer. It is based, at least in part, on the results of a comprehensive genome analysis on 241 prostate cancer samples (104 prostate cancer, 85 matched bloods, 49 matched benign prostate tissues adjacent to cancer, and 3 cell lines) which indicate that (i) genome copy number variation (CNV) occurred in both cancer and non-cancer tissues, and (ii) CNV predicts prostate cancer progression.